Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery. (2019)
Attributed to:
Defining the role of FOSL2 in molecular adaptation to hypoxia in colorectal cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1096/fj.201802603rr
PubMed Identifier: 31145643
Publication URI: http://europepmc.org/abstract/MED/31145643
Type: Journal Article/Review
Volume: 33
Parent Publication: FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Issue: 8
ISSN: 0892-6638